Gentle brain stimulation for movement and daily function in multiple sclerosis
Tests stimulation of the cerebellum against sham stimulation in adults with multiple sclerosis.
Key facts
- Who runs it
- University of Sharjah
- Where
- Sharjah city, United Arab EmiratesSee the site
- Trial code
- Registry title
- Bilateral Anodal Cerebellar tDCS for Multidomain Dysfunctions in Patients With Multiple Sclerosis
- Status
- Not yet recruiting
- People taking part
- 40 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 1 Jun 2028
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Bilateral Cerebellar Transcranial Direct Current Stimulation (ctDCS)
- Sham Bilateral Cerebellar tDCS
- Record updated
- 29 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with multiple sclerosis whose disease is stable and who take a stable disease-modifying therapy. It tests brain stimulation against sham stimulation.
- Age
- Adults, older than 18 years
- Sex
- All sexes can join
- Disease stage
- Confirmed multiple sclerosis (revised McDonald criteria), EDSS score between 2.0 and 6.0, clinically stable for at least 3 months
- Earlier treatment
- Stable disease-modifying therapy for at least 3 months
Main reasons for not taking part
- Multiple sclerosis relapse within the past 3 months
- History of epilepsy or seizures
- Implanted electronic device (such as a pacemaker) or metal implant in the head or skull
- Severe cognitive impairment that prevents taking part in the assessments
- Pregnancy or planned pregnancy during the study
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Confirmed diagnosis of Multiple Sclerosis according to the revised McDonald criteria
- Adult Age > 18 years
- Expanded Disability Status Scale (EDSS) score between 2.0 and 6.0
- Clinically stable disease status for at least 3 months prior to enrollment
- On stable disease-modifying therapy (DMT) for at least 3 months
- Ability to understand study procedures and provide informed consent
- Ability to ambulate independently or with assistive devices sufficient to complete motor assessments
Who cannot take part
- Metallic implants in the head or skull incompatible with transcranial magnetic stimulation (TMS)
- History of epilepsy or seizures
- Severe cognitive impairment preventing participation in assessments
- Other neurological or psychiatric disorders that may confound study outcomes
- Severe musculoskeletal or orthopedic conditions interfering with motor performance testing
- Multiple sclerosis relapse within the past 3 months
- Presence of implanted electronic devices (e.g., pacemaker, neurostimulator)
- Pregnancy or planned pregnancy during the study period
- Contraindications to non-invasive brain stimulation or TMS
Where in United Arab Emirates
- University of SharjahSharjah city, United Arab EmiratesContact: Hikmat Hadoush PhD, PhDNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if brain stimulation can improve movement and daily function in people with multiple sclerosis (MS). The study will also look at how this treatment affects fatigue, sleep, memory and attention, and quality of life.
Read full original descriptionShow less
The main questions this study aims to answer are the following:
Does this treatment improve coordination and balance? Does it reduce fatigue and improve sleep and daily life? Does it change brain activity?
Researchers will compare active brain stimulation to sham stimulation (a look-alike treatment that does not deliver real stimulation) to see if the treatment works.
Participants will:
Receive brain stimulation sessions for two weeks Attend assessment sessions before and after treatment Return for a follow-up visit after four weeks Complete tests of movement, fatigue, sleep, and thinking
The 2 groups in the trial
- Sham Bilateral Cerebellar tDCSSham treatment, for comparison
Participants in this arm will receive sham bilateral cerebellar transcranial direct current stimulation (ctDCS). Electrodes will be positioned identically to the active stimulation group (bilateral cerebellar montage). The device will deliver a brief ramp-up and ramp-down of current at the beginning and end of the session to mimic the sensation of active stimulation, but no continuous current will be applied. Each session will last 20 minutes, 5 sessions per week for 2 consecutive weeks (total of 10 sessions). This procedure is designed to maintain participant blinding.
- TDCS GROUPTreatment being tested
Participants in this arm will receive bilateral cerebellar transcranial direct current stimulation (ctDCS). Anodal electrodes will be positioned bilaterally over the cerebellar hemispheres (3 cm lateral to the inion), with reference electrodes placed over the buccinator muscles. Stimulation will be delivered at 2 mA for 20 minutes per session, 5 sessions per week for 2 consecutive weeks (total of 10 sessions). The intervention will be administered as a standalone neuromodulation protocol without concurrent task-oriented rehabilitation to isolate neuro-modulatory effects.
Treatment: Bilateral Cerebellar Transcranial Direct Current Stimulation (ctDCS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Bilateral Anodal Cerebellar tDCS for Multidomain Dysfunctions in Patients With Multiple Sclerosis: A Randomized Controlled Trial Study
- Plain-language title
- Gentle brain stimulation for movement and daily function in multiple sclerosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 29 April 2026